Red Blood Cell Eicosapentaenoic Acid Inversely Relates to MRI-Assessed Carotid Plaque Lipid Core Burden in Elders at High Cardiovascular Risk
暂无分享,去创建一个
D. Corella | N. Bargalló | P. Calder | M. Fitó | A. Sala-Vila | E. Ros | R. Estruch | M. Ruíz-Canela | J. Salas-Salvadó | R. Gilabert | M. Cofán | Edwin-Saúl Romero-Mamani | J. Salas‐Salvadó
[1] D. Mozaffarian,et al. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association , 2017, Circulation.
[2] M. Fornage,et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.
[3] S. Shrivastava,et al. Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes. , 2016, Biochimica et biophysica acta.
[4] A. Hoes,et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.
[5] T. Kooistra,et al. Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin. , 2016, Atherosclerosis.
[6] N. Salem,et al. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. , 2016, Progress in lipid research.
[7] K. Borow,et al. Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis. , 2015, Atherosclerosis.
[8] M. Lagarde,et al. Omega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis. , 2015, Biochimica et biophysica acta.
[9] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[10] A. Sannino,et al. Non-invasive vulnerable plaque imaging: how do we know that treatment works? , 2014, European heart journal cardiovascular Imaging.
[11] Stephen S. Lim,et al. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys , 2014, BMJ : British Medical Journal.
[12] K. Nasir,et al. Omega-3 Fatty Acid Blood Levels: Clinical Significance and Controversy , 2013, Circulation.
[13] P. Calder. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. , 2012, Molecular nutrition & food research.
[14] R. Erasmus,et al. Gas Chromatography Results Interpretation: Absolute Amounts Versus Relative Percentages , 2012 .
[15] R. Lamuela-Raventós,et al. Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD. , 2011, The British journal of nutrition.
[16] M. Pencina,et al. Carotid-wall intima-media thickness and cardiovascular events. , 2011, The New England journal of medicine.
[17] P. Calder,et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. , 2010, Atherosclerosis.
[18] A. Zampelas. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. , 2010, Atherosclerosis.
[19] W. Harris,et al. Biological variability of blood omega-3 biomarkers. , 2010, Clinical biochemistry.
[20] Dolores Corella,et al. Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain , 2010, British Journal of Nutrition.
[21] W. Harris. The omega-3 index: From biomarker to risk marker to risk factor , 2009, Current atherosclerosis reports.
[22] G. Boysen. European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.
[23] C. Brotons,et al. Prevalencia, distribución y variabilidad geográfica de los principales factores de riesgo cardiovascular en España. Análisis agrupado de datos individuales de estudios epidemiológicos poblacionales: estudio ERICE , 2008 .
[24] B. Fielding,et al. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.
[25] M. Grau,et al. Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999 , 2007 .
[26] Y. Matsuzawa,et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.
[27] O. Simonetti,et al. Multislice dark‐blood carotid artery wall imaging: A 1.5 T and 3.0 T comparison , 2006, Journal of magnetic resonance imaging : JMRI.
[28] E. Ros,et al. Influence of HDL Cholesterol on Preclinical Carotid Atherosclerosis in Familial Hypercholesterolemia , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[29] C. Yuan,et al. Quantitative Evaluation of Carotid Plaque Composition by In Vivo MRI , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[30] E. Ros,et al. Preclinical coronary atherosclerosis in a population with low incidence of myocardial infarction: cross sectional autopsy study , 2003, BMJ : British Medical Journal.
[31] R. Elosua,et al. Prevalence of angina pectoris in Spain , 1999, European Journal of Epidemiology.
[32] W C Willett,et al. Adjustment for total energy intake in epidemiologic studies. , 1997, The American journal of clinical nutrition.
[33] D. Corella,et al. COHORT PROFILE Cohort Profile : Design and methods of the PREDIMED study , 2012 .
[34] J. Banegas,et al. Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study. , 2008, Revista espanola de cardiologia.
[35] J. Marrugat,et al. [Analysis of trends in myocardial infarction case-fatality, incidence and mortality rates in Girona, Spain, 1990-1999]. , 2007, Revista espanola de cardiologia.
[36] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[37] A. Castro‐Beiras,et al. Prevalence of angina pectoris in Spain. PANES Study group. , 1999, European journal of epidemiology.